Acquisition of Mixed Lineage Leukemia Rearrangement in a Chronic Myeloid Leukemia Patient While on Imatinib

Adriana Zámečníkova

doi:10.4081/hr.2011.e13

You are currently viewing a new version of our website. To view the old version click .

Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Case Report

31 August 2011

Acquisition of Mixed Lineage Leukemia Rearrangement in a Chronic Myeloid Leukemia Patient While on Imatinib

Kuwait Cancer Control Center, Department of Hematology, P.O. Box 42262, Shuwaikh 70653, Kuwait

Hematol. Rep.2011, 3(2), e13;https://doi.org/10.4081/hr.2011.e13

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder with a specific genetic abnormality, the Philadelphia chromosome (Ph) translocation t(9;22)(q34;q11) generating the BCR-ABL1 gene fusion [...]

Keywords:

CML progression; MLL rearrengment; imatinib treatment

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Food-Borne Bacteremic Illnesses in Febrile Neutropenic Children

Tricuspid Regurgitant Velocity Elevation in a Three-Year Old Child with Sickle Cell Anemia and Recurrent Acute Chest Syndromes Reversed Not by Hydroxyurea but by Bone Marrow Transplantation